Biliary proteins inhibiting or promoting cholesterol crystallization are assumed to play a major role in cholesterol gallstone pathogenesis. We now report a new group of biliary proteins that bind to cholesterol crystals, modify crystal morphology, and inhibit cholesterol crystallization. Various glycoprotein mixtures were extracted from abnormal human gallbladder bile using lectin affinity chromatography on concanavalin A, lentil, and Helix pomatia columns and were added to supersaturated model bile. Independent of the protein mixtures added, from the cholesterol crystals harvested, the same four GPs were isolated having molecular masses of 16, 28, 63, and 74 kD, respectively. Each protein was purified using preparative SDS-PAGE, and influence on cholesterol crystallization in model bile was tested at 10 jig/ml. Crystal growth was reduced by 76% (GP63), 65% (GP16), 55% (GP74), and 40% (GP28), respectively. Thus, these glycoproteins are the most potent biliary inhibitors of cholesterol crystallization known so far. Evidence that the inhibiting effect on cholesterol crystallization is mediated via protein-crystal interaction was further provided from scanning electron microscopy studies. Crystals grown in presence of inhibiting proteins showed significantly more ordered structures. Incidence of triclinic crystals and regular aggregates was shifted from 30 to 70% compared with controls. These observations may have important implications for understanding the role of biliary proteins in cholesterol crystallization and gallstone pathogenesis. (J. Clin. Invest. 1995. 96:3009-3015.)
Introduction
Evidence was provided almost a decade ago that biliary proteins play an important role in cholesterol crystallization (1) (2) (3) . By combining lectin affinity chromatography and a newly developed crystal growth assay (4) in a systematic study, various glycoprotein mixtures were separated from normal human bile, some of which primarily promoted and others primarily inhibited crystallization (5) . Inhibiting activity was most potent in the Helix pomatia lectin-bound fraction from which a 120-kD heterodimer glycoprotein was isolated with subunits of 58 and 63 kD (6) . Inhibiting potency of the heterodimer, however, was lower than the effect of total Helix pomatia lectin-bound fraction indicating other inhibitors do exist. In this study we report a new subgroup of four biliary glycoproteins that adsorb to cholesterol crystals. Using this feature, we were able to identify and isolate these proteins from lectin-bound mixtures. All four glycoproteins are potent inhibitors of cholesterol crystal growth. Scanning electron microscopy reveals significant differences in crystal morphology when crystals are grown in the presence of these proteins. Our studies provide novel insights into the mechanism of action of biliary inhibitor proteins.
Methods
Chemicals. Sodium salts of taurocholic acid and taurodeoxycholic acids, a-D-methyl-mannopyranoside, and N-acetyl-a-D-galactosamine were obtained from Sigma Chemical Co. (St. Louis, MO), cholesterol from Eastman Kodak (Rochester, NY), and grade I egg yolk lecithin from Lipid Products (South Nutfield, UK). Concanavalin A (Con A)' Sepharose 4B, lentil lectin-sepharose 4B, Helixpomatia lectin-sepharose 6MB, Pharmalyt' 3-10, and Immobiline' Dry Strips were obtained from Pharmacia Fine Chemicals (Uppsala, Sweden). SDS, /3-mercaptoethanol, acrylamide, bisacrylamide, ammonium persulfonate, and TEMED (N,N,N',N'-tetramethylene diamine) were purchased from Bio-Rad Laboratories (Richmond, CA). All other chemicals and solvents were reagent or HPLC grade quality (Merck AG, Darmstadt, Germany; Fluka Chemie AG, Buchs, Switzerland; J. T. Baker Inc., Deventer, Netherlands). Glassware was washed in warm 2% (vol/vol, 60'C) detergent solution (PCC-54T; Pierce Chemical Co., Rockford, IL), followed by methanol washes and thorough rinsing with purified water before drying. The water was of Milli-Q-quality (Millipore Corp., Bedford, MA).
Solutions were filtered through 0.22-,um micropore filters (Millipore Corp.) and degassed before use for model bile preparation.
Analytical procedures. Lipids were quantified enzymatically (7-9) using commercially available kits for bile acids (Nycomed Pharmaceuticals, Oslo, Norway), lecithin (Texas International Laboratories, Houston, TX), and cholesterol (Boehringer Mannheim, Mannheim, Germany). Protein concentrations were measured using either the Coomassie blue dye-binding assay (Bio-Rad Laboratories) (10) or the bicinchoninic acid combined biuret method (Pierce Chemical Co.) (11).
1. Abbreviations used in this paper: Con A, concanavalin A; GP, glycoprotein; IL, concentration index; Ig, growth rate index; TBS, Tris-buffered saline. SDS-PAGE. Gels were run in the buffer system described by Laemmli (12) in a vertical electrophoresis cell under reducing conditions. Lyophilized proteins (1 pg) were resolubilized with 10 MI sample buffer containing 50 mM Tris-HCl, pH 6.8, containing 2% (wt/vol) SDS, 10% (vol/vol) glycerol, 10% (vol/vol) l3-mercaptoethanol, 0.004% (wt/vol) bromphenol blue, and 1 mM EDTA and heated for 10 min at 950C before loading to the gel (polyacrylamide gradient 8-18%, 0.1% SDS, cell: Biometra' Minigel G-41; Biomedizinische Analytik GmbH, Gottingen, Germany). After completion of electrophoresis, proteins were fixed in the gels for 30 min in a watery solution of 40% ethanol and 10% acetic acid (vol/vol) and stained with silver nitrate (13).
For preparative electrophoresis, 100 jg of lyophilized Helix pomatia lectin-bound proteins were resolubilized in 100 ,l sample buffer containing 0.2% (wt/vol) SDS, and incubated for 12 h at 250C before separation in a homogeneous 15% polyacryamide gel (125 x 125 x 0.75 mm3, 0.1% SDS, cell: 2001; LKB, Uppsala, Sweden). Protein bands were identified using reversible staining (Copper Stain; Bio-Rad Laboratories). Corresponding gel segments were cut, destained, and proteins were recovered by electroelution (422; Bio-Rad Laboratories) using a 50-mM ammonium bicarbonate/0.005% SDS (wt/vol) elution buffer. Matched gel segments without proteins were equally processed and used as equivalent internal control.
Isoelectric focusing and two-dimensional gel electrophoresis. Analytical isoelectric focusing was performed according to manufacturer's protocol using gels with immobilized pH gradients (Immobilinet' Dry Strips, pH gradient 3-10; Pharmacia Fine Chemicals) ( 14) . Lyophilized protein samples (3 100 ,000 g at 4°C to remove insoluble constituents. The soluble phase was directly loaded to either a concanavalin A or a lentil lectin column (1 ml bile/I ml gel) and recycled for 12 h. Before loading the sample, columns (50 ml gel in a column of 2.5 x 20 cm) were prewashed with 250 ml 20 mM Tris-HCl starting buffer, pH 7.4, containing 0.2 M NaCl and 3 mM NaN3 as antimicrobial agent. After recycling, all unbound components were removed from the column by washing with > 250 ml of starting buffer containing 3 mM sodium taurocholate until optical density of the eluent reached constant values. Subsequently, bound fractions were eluted with 250 ml of starting buffer supplemented with 0.25 M a-D-methylmannopyranoside. The lectin-bound fractions were concentrated to 10 ml by ultrafiltration, and buffer was exchanged to 20 mM ammonium bicarbonate by diafiltration on a YM 10 filter (Amicon Corp., Danvers, MA). Aliquots of both lectin-bound glycoprotein fractions were further purified by chromatography on a Helix pomatia lectin column (20 ml gel in 2.5 X 20 cm column, 0.5 mg protein/ml gel) using the same procedure as described above. The bound glycoproteins were eluted with 100 ml starting buffer supplemented with 0.5 M N-acetyl-a-D-galactosamine.
Model bile. Concentrations of stock solutions (taurocholate and cholesterol, both in methanol, and lecithin in chloroform-methanol 2:1 [vol/ vol]) were determined as described above. Appropriate aliquots of stock solutions were calculated from Carey's critical tables (15) , coprecipitated, dried under nitrogen, and subsequently lyophilized as previously described (4) . The dried lipid film was dissolved in Tris-buffered saline (TBS) (25 mM Tris-HCl, pH 7.45, 150 mM NaCl) containing 3 mM NaN3. The suspension was then incubated at 60'C for 6 h, and the clear solution was filtered through a preheated 0. Cholesterol crystal growth curves were analyzed using split plot ANOVA to determine differences between study groups assigning the time to be the split factor. Sequential multiple comparisons were performed at the 5% (P < 0.05) level using the procedure of Bonferonni (16 
Results
Crystal-binding proteins. Protein fractions bound to Con A and lentil lectins differed significantly in number of bands and relative distributions of proteins when compared by SDS-PAGE (Fig. 1) , although both columns are supposed to have similar binding specificity. This is in agreement with separations using molecular sieving chromatography before lectin affinity chromatography (5). Recovery of proteins was 10% for the Con A and 5% for lentil lectin columns. Using subsequent chromatography on a Helix pomatia lectin column, the protein mixture separated showed the same number and positions of protein bands. However, different intensities of individual bands were observed corresponding to differences in relative amounts of proteins.
From each of the four lectin-bound fractions we determined the proteins that attach to cholesterol crystals grown in model bile solutions at pH 7.45. Independent of the fraction added to the model bile, we isolated the same set of crystal-binding proteins. This new subgroup is formed by four proteins having molecular masses of 16, 28, 63, and 74 kD, respectively (Fig.  2, bottom) . Each protein band consisted of several isoforms with pI in the range of pH 6.3-8.3 as determined by twodimensional gel electrophoresis. The smeared background in the range of 50-80 kD resulted from traces of cholesterol in the crystal-bound protein samples. Comparing the two-dimensional gels of proteins bound to cholesterol crystals with those of the lectin-bound proteins that were added to model bile before starting crystal growth (Fig. 2, top) , we found only isoforms binding to crystals with pI within ± 1 pH U of the model bile pH.
Crystal morphology. Scanning electron microscopy studies were performed to assess changes in crystal morphology when grown in the presence of effector proteins. We found the following typical classes of crystals sufficient to characterize populations of crystals grown in our experiments (Fig. 3) .
The basic unit was the platelike crystal showing either the euhedral triclinic form with straight edges and a smooth surface or the polycyclic form with multiple cyclic edges and many screwed and stepwise dislocations (Fig. 3, 1 and 4) . These crystal plates tended to aggregate in a fashion in which the euhedral crystals mainly formed aggregates orderly aligned along the main crystallographic axes of the triclinic crystal, while polycyclic plates preferred random aggregation (Fig. 3,  2 and 5 ). In addition, we found polycyclic plates radially arranged thus forming a cluster of -200 tim opening up widely into space (Fig. 3, 6 ). In contrast, we also found radial arrangements of smooth triclinic crystal plates with little free space between the plates representing small compact microliths (Fig.  3, 3) . Remarkably, some euhedral crystals exhibited the shape of thick rhombic crystal plates with smooth surfaces and only few dislocations (Fig. 3, 8 ). These compact microliths were observed in particular at the end of the growth experiments and may be considered as the most effective deposit for cholesterol. Some concrements were seen with an irregular surface unlike typical platelike cholesterol crystals. These are referred to as amorphous concrements in Fig. 3, 9 . In addition, only in early stages of crystal growth, we saw many rodlike structures with drumsticklike augmentations at one end representing evolving crystal plates (Fig. 3, 7) . These structures have recently been described by Konikoff et al. (17) . To the same in all experiments. The picture was quite different when crystals were grown in the presence of lectin-bound biliary effector proteins. Compared to control, these populations showed a marked increase in frequencies of regular crystal forms (60-70%) and a decrease in irregular structures to -30%. The incidences of these two classes were almost inverted compared to control. Since both Helix pomatia lectin- bound fractions induced the same effect on crystal morphology, the numbers in Table I represent mean values. Statistical analysis revealed a highly significant overall difference in distribution across the morphological classes (P < 0.001). All three proteinrelated distributions were significantly different from control (P < 0.001) but not among each other (P > 0.1). Therefore, the three protein-related distributions were collapsed into one group, and the four morphological classes were compared to those of the control condition using Fisher's exact test for 2 by 2 tables. Polycyclic crystals and random aggregates (P < 0.001) as well as clusters (P < 0.004) were significantly more frequent in control, whereas triclinic crystals and regular aggregates were significantly less frequent (P < 0.001). There was no significant difference in the incidence of amorphous concrements.
Cholesterol crystal growth. The four glycoproteins that had been identified by the crystal-binding studies were individually purified from the Helix pomatia lectin-bound fraction of abnormal human bile using preparative SDS-PAGE. A single band for each of the four glycoproteins was obtained as estimated by analytical SDS-PAGE gel with silver staining (Fig. 4) . To assess their influence on cholesterol crystallization, we tested each protein at a final concentration of 10 jig/ml using the crystal growth assay in model bile (4) . Control curves were measured in triplicate and protein-related curves were measured in duplicate. Growth curves were normalized to the final plateau of 
Discussion
Biliary proteins, either promoting or inhibiting cholesterol crystallization, are assumed to contribute to a balance of effects influencing the physical chemistry of supersaturated bile thereby modifying nucleation and growth of crystals ( 18, 19) . These crystals probably agglomerate via mucin glycoproteins before forming mature cholesterol gallstones (20, 21) . Progress in purifying biliary effector proteins had been slow until lectin affinity chromatography was introduced to separate glycoproteins from bile (22, 23) . Since then several crystallization-promoting proteins have been reported. These include a 130-kD glycoprotein (23) which recently was shown to be aminopeptidase N (24) , biliary Igs (25), a-1 acid glycoprotein (26) , phospholipase C (27) , and fibronectin (28) . As to inhibiting activity, however, only a 120-kD heterodimer glycoprotein with subunits of 58 and 63 kD was isolated from Helix pomatia lectin-bound proteins of normal human bile (6 We report new data on inhibition of cholesterol crystallization by biliary proteins. A new subgroup of four glycoproteins was isolated from different lectin-bound protein fractions that were known to contain both promoting and inhibiting factors of cholesterol crystallization (5) . The unique quality that we used to identify and isolate this subgroup of proteins was their ability to bind to cholesterol crystals, therefore we refer to these compounds as crystal-binding proteins. Analysis of the lectinbound protein fractions compared to the crystal-binding proteins by two-dimensional electrophoresis demonstrated that all four glycoproteins consist of several isoforms. Only those with pl within a range of ±1 pH U around the pH of the model bile were capable of crystal binding. All four proteins were enriched using Helix pomatia lectin affinity chromatography, which is supposed to preferentially bind N-acetyl-a-D-galactosamine residues (29) .
The four glycoproteins proved to be potent inhibitors of cholesterol crystal growth in model bile (Fig. 5) , actually the most potent inhibitors isolated from human bile so far. They reduced the kinetics of crystallization (growth rate) and the final crystal concentration with the 28-kD protein showing the strongest inhibiting effect. Even our protein with the lowest inhibiting potency performed better than the recently reported 58/63-kD heterodimer (6) . Promoter proteins, although known to be present in the lectin-bound protein fractions (5), were not found among the crystal-binding proteins.
Crystal morphology was significantly changed in the presence of lectin-bound proteins favoring growth of euhedral triclinic crystals with smooth surfaces which tended to form regular aggregates or compact microliths. We found similar forms of crystals as those described by Toor et ( 17) . This mechanism would require only small amounts of inhibitors. Also the final crystal concentration would be decreased, since a higher activity of free cholesterol in bile would be required for further apposition of cholesterol molecules to the crystal (33, 34) . This interpretation is supported by the changes of both crystal growth curve parameters, and, recalling the data on cholesterol crystal structure and growth thermodynamics (35, 36) , could explain the observed preference for compact euhedral crystals.
Other evidence has been reported which indicates the special property of glycoproteins to inhibit crystal growth in biological systems. In sera of polar fish, "antifreeze proteins" prevent the formation of ice (37, 38) . They presumably adsorb to ice crystals, thus inhibiting the normal propagation of ice-growth steps or layers across the surface (39) . A similar mechanism may also apply to freeze tolerance in insects (40) . Glycoproteins regulate the precipitation of calcium salts in bone and dentin formation (41) . Regarding stone formation in humans, three different inhibitor proteins of calcium carbonate or oxalate precipitation have been isolated: a 14-kD glycoprotein inhibitor prevents formation of calcium oxalate nephrolithiasis in healthy subjects (42, 43) , a small acidic glycoprotein from human pancreatic calculi inhibits calcium carbonate precipitation (44, 45 ) , and, finally, a small (< 10-kD) glycoprotein isolated from cholesterol gallstones tightly binds bile pigment and strongly inhibits precipitation of calcium carbonate in vitro (46) .
Preliminary data from our laboratory indicate that the cholesterol crystal-binding proteins are subunits of polymeric human IgA (47, 48). A full characterization of these proteins is currently prepared for publication.
The observations reported in this paper may contribute to the understanding of cholesterol gallstone pathogenesis. The irregular aggregates and the clusters of crystals that predominated in the populations grown without inhibitor proteins may form a nidus for deposition of biliary mucus, pigment, and precipitates of calcium and its sensitive anions, bilirubinate and carbonate. All these compounds, which are major constituents of biliary sludge (49) , are almost always found in the centers of cholesterol gallstones (50) . We found inhibitor proteins increasing the frequency of compact crystals and regular aggregates even in those samples that contained potent antagonistic promoting factors (5) . Compact crystals may be considered as the most effective deposit for cholesterol in bile and are normally removed by gallbladder contraction. In human gallstone disease, highly correlated with gallbladder motor dysfunction (51) , these crystals may accumulate in bile and provide the substrate for gallstone formation. The observed crystal morphologies correlate to scanning electron microscopy studies of human gallstones (52) , showing a well-ordered arrangement of compact crystals in slowly growing solitary cholesterol gallstones. In contrast, in fast-growing multiple cholesterol stones, unsettled crystals forming random aggregates were found being radially arranged in a perpendicular position to the center of the hemisphere.
We conclude that depending on the balance of promoters and inhibitors in bile inhibiting activity either impedes cholesterol crystallization or retards subsequent mechanisms of gallstone formation thus favoring well-ordered arrangements of stone-forming crystals.
